Skip to content
Screener

Repligen RGEN Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Revvity logo
RevvityRVTY
$11.07M-41.3%
Haemonetics logo
HaemoneticsHAE
$7.91M+111%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$1.56M+183%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$204.1M+11.9%
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
Net income$5.0M-66.3%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%
Total assets$3.0B+1.7%

Cash flow

See full
Operating cash flow$32.8M+14.5%
CapEx$5.3M-24.9%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$9.25B+47.6%
Enterprise value$9.33B+63.4%
P/E222.7×
P/S12×+0.4×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Repligen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323773
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Purchases of marketable securities(130,698)
Maturities of marketable securities132,000
Additions to capitalized software costs(972)(1,371)
Purchases of property, plant and equipment(10,044)(10,664)
Sale of property, plant and equipment42
Total cash used in investing activities(6,077)(81,947)
Cash flows for financing activities
Proceeds from exercise of stock options941,464

ITEM 1. Financial Statements

FAQ

What is Repligen's payments to acquire property, plant, and equipment?
Repligen (RGEN) reported payments to acquire property, plant, and equipment of $5.33M in Q2 2026.
How has Repligen's payments to acquire property, plant, and equipment changed year-over-year?
Repligen's payments to acquire property, plant, and equipment decreased by 24.9% year-over-year, from $7.1M to $5.33M.
What is the long-term trend for Repligen's payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), Repligen's payments to acquire property, plant, and equipment has grown at a -23.1% compound annual growth rate (CAGR), from $67.09M to $23.52M.
What does payments to acquire property, plant, and equipment mean?
Measures cash outflows for capital expenditures on physical assets such as facilities, machinery, and equipment. It serves as a key indicator of the company's investment in long-term production capacity and operational infrastructure.

Ask your AI about Repligen's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude